AWD 131138

Drug Profile

AWD 131138

Alternative Names: ADD 233089

Latest Information Update: 24 Aug 2007

Price : $50

At a glance

  • Originator elbion
  • Class Antiepileptic drugs; Anxiolytics; Neuroprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Anxiety disorders; Epilepsy

Most Recent Events

  • 29 Nov 2001 No-Development-Reported for Epilepsy in Germany (Unknown route)
  • 29 Nov 2001 No-Development-Reported for Anxiety disorders in Germany (Unknown route)
  • 07 Sep 2000 Phase-I clinical trials for Epilepsy in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top